Tempol, a Superoxide Dismutase Mimetic Agent, Inhibits Superoxide Anion-Induced Inflammatory Pain in Mice
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
The present study evaluated the anti-inflammatory and analgesic effects of the superoxide dismutase mimetic agent tempol in superoxide anion-induced pain and inflammation. Mice were treated intraperitoneally with tempol (10–100 mg/kg) 40 min before the intraplantar injection of a superoxide anion donor, potassium superoxide (KO 2, 30 μ g). Mechanical hyperalgesia and thermal hyperalgesia, paw edema, and mRNA expression of peripheral and spinal cord mediators involved in inflammatory pain, TNF α, IL-1 β, IL-10, COX-2, preproET-1, gp91phox, Nrf2, GFAP, and Iba-1, were evaluated. Peripheral and spinal cord reductions of antioxidant defenses and superoxide anion were also assessed. Tempol reduced KO 2-induced mechanical hyperalgesia and thermal hyperalgesia and paw edema. The increased mRNA expression of the evaluated mediators and oxidative stress in the paw skin and spinal cord and increased mRNA expression of glial markers in the spinal cord induced by KO 2 were successfully inhibited by tempol. KO 2-induced reduction in Nrf2 mRNA expression in paw skin and spinal cord was also reverted by tempol. Corroborating the effect of tempol in the KO 2 model, tempol also inhibited carrageenan and CFA inflammatory hyperalgesia. The present study demonstrates that tempol inhibits superoxide anion-induced molecular and behavioral alterations, indicating that tempol deserves further preclinical studies as a promising analgesic and anti-inflammatory molecule for the treatment of inflammatory pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Tempol inhibits KO2-induced hyperalgesia and paw edema. Mice were treated with tempol (10–100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Nociceptive thresholds to mechanical (a) and thermal (b) stimuli as well as paw edema (c) were measured 1–5 h after KO2 injection. Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle; ∗∗p < 0.05 versus KO2 + tempol 10 mg/kg; ##p < 0.05 versus KO2 + tempol 30 mg/kg (ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/40a2cf62c8a94a8d80cd33deb8e5e142/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-1.jpg)
![Figure 2 Tempol inhibits KO2-induced TNFα, IL-1β, and IL-10 mRNA expression in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and TNFα ((a) and (b)), IL-1β ((c) and (d)), and IL-10 ((e) and (f)) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/e11ea648e3754f1c82da3860170303b5/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-2.jpg)
![Figure 3 Tempol inhibits KO2-induced COX-2 and preproET-1 mRNA expressions in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and COX-2 ((a) and (b)) and preproET-1 ((c) and (d)) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/ff6525b5a23442af85c66eed776511d4/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-3.jpg)
![Figure 4 Tempol inhibits KO2-induced depletion of antioxidant capacity in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and the oxidant capacity was evaluated by FRAP ((a) and (b)), ABTS ((c) and (d)), and GSH ((e) and (f)) assays. Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/19a0e66609774a44ae18c6bb97dcc962/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-4.jpg)
![Figure 5 Tempol inhibits KO2-induced oxidative stress in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2 injection to evaluate gp91phox mRNA expression ((a) and (b)) and NBT reduction (superoxide anion production assay, (c) and (d)) by qPCR and colorimetric assay, respectively. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/8abd4e8baa354d5094fdc52c21129055/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-5.jpg)
![Figure 6 Tempol inhibits KO2-induced decrease of Nrf2 mRNA expression in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2 injection and Nrf2 mRNA expression was evaluated by qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/d848ebc95a12449f887330fbb16c700b/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-6.jpg)
![Figure 7 Tempol inhibits KO2-induced astrocytes and microglia activation in the spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Spinal cord samples were collected 3 h after KO2 injection and GFAP (a) and Iba-1 (b) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/82debfa8c81241feb6e1539960132cbb/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-7.jpg)
![Figure 8 Tempol inhibits carrageenan and complete Freund's adjuvant- (CFA-) induced hyperalgesia. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before carrageenan or CFA intraplantar injection. Nociceptive thresholds to mechanical and thermal stimuli were measured 1–5 h after carrageenan injection (panels (a) and (b), resp.) and 1–7 days after CFA injection (panels (c) and (d), resp.). Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus carrageenan + vehicle for panels (a)-(b) and versus CFA + vehicle for panels (c)-(d) (ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/83e5f90e5e584a90b1354ab36adbdbba/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-8.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However since O2●− is removed, its cellular role can be investigated with this substance [30,372].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [372]
In the citing paper
“Tempol (4-Hydroxy-Tempo) is a SOD mimetic and catalyzes the dismutation of O2●− into H2O2.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [372]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish
Niethammer, P., Grabher, C., Look, A. T., & Mitchison, T. J. (2009) · Nature · doi:10.1038/nature08119 · Cited by 1,541
Central sensitization and LTP: do pain and memory share similar mechanisms?
Ji, R.-R., Kohno, T., Moore, K. A., & Woolf, C. J. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.09.017 · Cited by 1,463
Nociceptor Sensory Neuron–Immune Interactions in Pain and Inflammation
Pinho-Ribeiro, F. A., Verri, W. A., & Chiu, I. M. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.10.001 · Cited by 1,027
Self-citationNeutrophils cascading their way to inflammation
Sadik, C. D., Kim, N. D., & Luster, A. D. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.008 · Cited by 577
Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?
Verri, W. A., Cunha, T. M., Parada, C. A., Poole, S., Cunha, F. Q., & Ferreira, S. H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.001 · Cited by 542
Effects of tempol and redox-cycling nitroxides in models of oxidative stress
Wilcox, C. S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.003 · Cited by 465
A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma
Caceres, A. I., Brackmann, M., Elia, M. D., Bessac, B. F., del Camino, D., D'Amours, M., Witek, J. S., Fanger, C. M., Chong, J. A., Hayward, N. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900591106 · Cited by 463
An electronic pressure-meter nociception paw test for mice
Cunha, T. M., Verri Jr., W. A., Vivancos, G. G., Moreira, I. F., Reis, S., Parada, C. A., Cunha, F. Q., & Ferreira, S. H. (2004) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2004000300018 · Cited by 459
TRPA1 is a major oxidant sensor in murine airway sensory neurons
Bessac, B. F., Sivula, M., von Hehn, C. A., Escalera, J., Cohn, L., & Jordt, S.-E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34192 · Cited by 449
A Newly Identified Role for Superoxide in Inflammatory Pain
Wang, Z.-Q., Porreca, F., Cuzzocrea, S., Galen, K., Lightfoot, R., Masini, E., Muscoli, C., Mollace, V., Ndengele, M., Ischiropoulos, H., et al. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064154 · Cited by 387
Roles of reactive oxygen and nitrogen species in pain
Salvemini, D., Little, J. W., Doyle, T., & Neumann, W. L. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.026 · Cited by 295
Sod mimetics are coming of age
Salvemini, D., Riley, D. P., & Cuzzocrea, S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd796 · Cited by 260
Vitexin Inhibits Inflammatory Pain in Mice by Targeting TRPV1, Oxidative Stress, and Cytokines
Borghi, S. M., Carvalho, T. T., Staurengo-Ferrari, L., Hohmann, M. S. N., Pinge-Filho, P., Casagrande, R., & Verri, W. A. (2013) · Journal of Natural Products · doi:10.1021/np400222v · Cited by 225
Self-citationKatalinic, V., Modun, D., Music, I., & Boban, M. (2005) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/j.cca.2005.01.005 · Cited by 224
Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐4
Cunha, F. Q., Poole, S., Lorenzetti, B. B., Veiga, F. H., & Ferreira, S. H. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702266 · Cited by 222
Henderson, L. M., & Chappell, J. B. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(95)00140-9 · Cited by 207
IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice
Verri, W. A., Guerrero, A. T. G., Fukada, S. Y., Valerio, D. A., Cunha, T. M., Xu, D., Ferreira, S. H., Liew, F. Y., & Cunha, F. Q. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712116105 · Cited by 185
Milligan, E. D., Sloane, E. M., Langer, S. J., Cruz, P. E., Chacur, M., Spataro, L., Wieseler-Frank, J., Hammack, S. E., Maier, S. F., Flotte, T. R., et al. (2005) · Molecular Pain · doi:10.1186/1744-8069-1-9 · Cited by 181
Inhibition of Lipid Peroxidation by Spin Labels
Nilsson, U. A., Olsson, L. I., Carlin, G., & Bylund-Fellenius, A. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60439-9 · Cited by 176
Manchope, M. F., Calixto-Campos, C., Coelho-Silva, L., Zarpelon, A. C., Pinho-Ribeiro, F. A., Georgetti, S. R., Baracat, M. M., Casagrande, R., & Verri, W. A., Jr. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153015 · Cited by 168
Self-citationCytokine‐mediated inflammatory hyperalgesia limited by interleukin‐10
Poole, S., Cunha, F. Q., Selkirk, S., Lorenzetti, B. B., & Ferreira, S. H. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb14987.x · Cited by 162
Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain
Zarpelon, A. C., Rodrigues, F. C., Lopes, A. H., Souza, G. R., Carvalho, T. T., Pinto, L. G., Xu, D., Ferreira, S. H., Alves‐Filho, J. C., McInnes, I. B., et al. (2016) · The FASEB Journal · doi:10.1096/fj.14-267146 · Cited by 161
Self-citationKhattab, M. M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.007 · Cited by 122
Reducing and Oxidizing Agents Sensitize Heat-Activated Vanilloid Receptor (TRPV1) Current
Sušánková, K., Tousova, K., Vyklický, L., Teisinger, J., & Vlachová, V. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023069 · Cited by 122
Tal, M. (1996) · Neuroreport · doi:10.1097/00001756-199605310-00010 · Cited by 119
Maitra, U., Singh, N., Gan, L., Ringwood, L., & Li, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059501 · Cited by 113
Calil, I. L., Zarpelon, A. C., Guerrero, A. T. G., Alves-Filho, J. C., Ferreira, S. H., Cunha, F. Q., Cunha, T. M., & Verri, W. A., Jr. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090013 · Cited by 109
Self-citationRegulation of TNF-induced oxygen radical production in human neutrophils: role of δ-PKC
Kilpatrick, L. E., Sun, S., Li, H., Vary, T. C., & Korchak, H. M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0408230 · Cited by 95
Ndengele, M. M., Muscoli, C., Wang, Z. Q., Doyle, T. M., Matuschak, G. M., & Salvemini, D. (2005) · Shock · doi:10.1097/01.shk.0000144130.36771.d6 · Cited by 93
Jiménez‐Altayó, F., Briones, A. M., Giraldo, J., Planas, A. M., Salaíces, M., & Vila, E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088435 · Cited by 93
Muscoli, C., Mollace, V., Wheatley, J., Masini, E., Ndengele, M. M., Wang, Z., & Salvemini, D. (2004) · Pain · doi:10.1016/j.pain.2004.06.004 · Cited by 91
Oxygen and the inflammatory cell
Nathan, C. (2003) · Nature · doi:10.1038/422675a · Cited by 90
5-Lipoxygenase Deficiency Reduces Acetaminophen-Induced Hepatotoxicity and Lethality
Hohmann, M. S., Cardoso, R. D. R., Pinho-Ribeiro, F. A., Crespigio, J., Cunha, T. M., Alves-Filho, J. C., da Silva, R. V., Pinge‐Filho, P., Ferreira, S. H., Cunha, F. Q., et al. (2013) · BioMed Research International · doi:10.1155/2013/627046 · Cited by 86
Self-citationIvan, A. L. M., Campanini, M. Z., Martinez, R. M., Ferreira, V. S., Steffen, V. S., Vicentini, F. T. M. C., Vilela, F. M. P., Martins, F. S., Zarpelon, A. C., Cunha, T. M., et al. (2014) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2014.05.010 · Cited by 85
Self-citationMicroassay of superoxide anion scavenging activity in vitro
Laight, D. W., Andrews, T., Haj-Yehia, A. I., CARRIER, M. J., & Änggård, E. (1997) · Environmental Toxicology and Pharmacology · doi:10.1016/s1382-6689(96)00143-3 · Cited by 78
Activation of cardiac vagal afferents by oxygen-derived free radicals in rats.
Ustinova, E. E., & Schultz, H. D. (1994) · Circulation Research · doi:10.1161/01.res.74.5.895 · Cited by 78
Maioli, N. A., Zarpelon, A. C., Mizokami, S. S., Calixto-Campos, C., Guazelli, C. F. S., Hohmann, M. S., Pinho-Ribeiro, F. A., de Carvalho, T. T., Manchope, M. F., Ferraz, C. R., et al. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20144187 · Cited by 73
Self-citationCross-talk between IRAK-4 and the NADPH oxidase
Pacquelet, S., Johnson, J. L., Ellis, B. A., Brzezinska, A. A., Lane, W. S., Munafo, D. B., & Catz, S. D. (2007) · Biochemical Journal · doi:10.1042/bj20061184 · Cited by 71
Antigen-induced inflammatory mechanical hypernociception in mice is mediated by IL-18
Verri, W. A., Jr., Cunha, T. M., Parada, C. A., Poole, S., Liew, F. Y., Ferreira, S. H., & Cunha, F. Q. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.11.005 · Cited by 70
Capsaicin receptors mediate free radical-induced activation of cardiac afferent endings
Schultz, H. D., & Ustinova, E. E. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00031-5 · Cited by 67
Borghi, S. M., Pinho-Ribeiro, F. A., Fattori, V., Bussmann, A. J. C., Vignoli, J. A., Camilios‐Neto, D., Casagrande, R., & Verri, W. A., Jr. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162267 · Cited by 65
Self-citationAli, M. R. A., Abo‐Youssef, A. M., Messiha, B. A. S., & Khattab, M. M. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1234-6 · Cited by 64
Superoxide anion-induced pain and inflammation depends on TNFα/TNFR1 signaling in mice
Borin, F. Y. Y., Zarpelon, A. C., Pinho-Ribeiro, F. A., Fattori, V., Alves-Filho, J. C., Cunha, F. Q., Cunha, T. M., Casagrande, R., & Verri, W. A., Jr. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.08.015 · Cited by 60
Self-citationAnalgesic activity of piracetam: Effect on cytokine production and oxidative stress
Navarro, S. A., Serafim, K. G. G., Mizokami, S. S., Hohmann, M. S., Casagrande, R., & Verri, W. A., Jr. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.02.018 · Cited by 56
Self-citationKim, H. K., Hwang, S.-H., & Abdi, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00532 · Cited by 51
Interleukin‐10 limits intense acute swimming‐induced muscle mechanical hyperalgesia in mice
Borghi, S. M., Pinho-Ribeiro, F. A., Zarpelon, A. C., Cunha, T. M., Alves-Filho, J. C., Ferreira, S. H., Cunha, F. Q., Casagrande, R., & Verri, W. A., Jr. (2015) · Experimental Physiology · doi:10.1113/ep085026 · Cited by 36
Self-citationSerafim, K. G. G., Navarro, S. A., Zarpelon, A. C., Pinho-Ribeiro, F. A., Fattori, V., Cunha, T. M., Alves-Filho, J. C., Cunha, F. Q., Casagrande, R., & Verri, W. A., Jr. (2015) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1160-z · Cited by 35
Self-citationExperimental evidence for the therapeutic potential of tempol in the treatment of acute liver injury
Abouzied, M. M., Eltahir, H. M., Taye, A., & Abdel-Rahman, M. S. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2572-2 · Cited by 29
Zhao, B., Pan, Y., Wang, Z., Tan, Y., & Song, X. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0274-7 · Cited by 26
Fattori, V., Serafim, K. G. G., Zarpelon, A. C., Borghi, S. M., Pinho-Ribeiro, F. A., Alves-Filho, J. C., Cunha, T. M., Cunha, F. Q., Casagrande, R., & Verri, W. A., Jr. (2016) · Journal of drug targeting · doi:10.1080/1061186x.2016.1245308 · Cited by 20
Self-citationKim, W. M., Jeong, C. W., Lee, S. H., Kim, Y. O., Cui, J. H., & Yoon, M. H. (2011) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318227824e · Cited by 19
Koriauli, S., Natsvlishvili, N., Barbakadze, T., & Mikeladze, D. (2015) · Biological Research · doi:10.1186/s40659-015-0048-1 · Cited by 19
Research works printed but not linked: 4
- 2016, Frontiers in Pharmacology, 7, 532
- 1898, Journal of Biological Chemistry, 264, 11131
- 2016, PLoS ONE, 11
- 2016, PLoS ONE, 11
Cited by
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
Superoxide Dismutase Administration: A Review of Proposed Human Uses
Rosa, A. C., Corsi, D., Cavi, N., Bruni, N., & Dosio, F. (2021) · Molecules · doi:10.3390/molecules26071844 · Cited by 256
Superoxide dismutase and neurological disorders
Chidambaram, S. B., Anand, N., Varma, S. R., Ramamurthy, S., Vichitra, C., Sharma, A., Mahalakshmi, A. M., & Essa, M. M. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.11.007 · Cited by 174
Li, L., Guo, J., Wang, Y., Xiong, X., Tao, H., Li, J., Jia, Y., Hu, H., & Zhang, J. (2018) · Advanced Science · doi:10.1002/advs.201800781 · Cited by 160
Potential Therapeutic Applications of MnSODs and SOD‐Mimetics
Bonetta, R. (2018) · Chemistry – A European Journal · doi:10.1002/chem.201704561 · Cited by 134
Metadata
- Authors
- Bernardy, C. C. F., Zarpelon, A. C., Pinho-Ribeiro, F. A., Calixto-Campos, C., Carvalho, T. T., Fattori, V., Borghi, S. M., Casagrande, R., & Verri, W. A.
- Affiliations
- Department of Nursing, Health Science Centre, State University of Londrina, Londrina, PR, Brazil
- Universidade Estadual de Londrina (BR)
- Department of Pathology, Biological Science Centre, State University of Londrina, Londrina, PR, Brazil
- Department of Pharmaceutical Sciences, Health Science Centre, State University of Londrina, Londrina, PR, Brazil
- ORCID
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-15
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC5446866
- OpenAlex
- W2613348303
- Cited by
- 40
- References
- 52
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 9 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 1
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Ministério da Ciência Tecnologia e Inovação
- Secretaria da Ciência, Tecnologia e Ensino Superior
- Fundação Araucária
- Parana State Government
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- tempol, superoxide dismutase mimetic, inflammatory pain, superoxide, potassium superoxide, oxidative stress, Nrf2, mechanical hyperalgesia, thermal hyperalgesia, paw edema, glial activation, TNF-α, IL-1β, IL-10, cyclooxygenase-2, endothelin-1, gp91phox, carrageenan-induced inflammation, complete Freund's adjuvant, analgesics, anti-inflammatory agents
- MeSH terms
- NADPH Oxidase 2, Animals, Calcium-Binding Proteins, Cyclic N-Oxides, Glial Fibrillary Acidic Protein, Male, Mice, Inbred BALB C, Microfilament Proteins, Pain, Spin Labels, Superoxides, Superoxide Dismutase, Cytokines, Biomimetic Materials, NF-E2-Related Factor 2, Mice, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.